Aeja Weiss, MD in Apo, AP - Dermatology

Aeja Weiss, MD is a Dermatology physician based in Apo, Armed Forces Pacific. Aeja Weiss is licensed to practice in Virginia (license number 0101270792) and her current practice location is Unit 5071, Apo, Armed Forces Pacific. She can be reached at her office (for appointments etc.) via phone at (315) 225-7508.

NPI number for Aeja Weiss is 1801352539 and her current mailing address is Unit 5071, Apo, Armed Forces Pacific. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1801352539.

Contact Information

	Aeja Weiss, MD
	Unit 5071, Apo, AP 96328-5071
	(315) 225-7508
	Not Available

Physician's Profile

Full Name	Aeja Weiss
Gender	Female
Speciality	Dermatology
Location	Unit 5071, Apo, Armed Forces Pacific
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1801352539
Provider Enumeration Date: 02/19/2019
Last Update Date: 07/31/2023

Medical Identifiers

Medical identifiers for Aeja Weiss such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1801352539	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	0101270792 (Virginia)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Secondary
207N00000X	Dermatology	0101270792 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Aeja Weiss is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Aeja Weiss, MD Unit 5071, Apo, AP 96328-5071 Ph: () -	Aeja Weiss, MD Unit 5071, Apo, AP 96328-5071 Ph: (315) 225-7508

News Archive

AstraZeneca 2010 third quarter decreases 2% to $7,898 million

Anglo-Swedish pharmaceutical company AstraZeneca announced that revenue for the third quarter declined by 2% at constant exchange rates (CER) to $7,898 million.

Smoke-free air law does not affect off-track betting facility business in Indiana

An Indiana University study found that a smoke-free air law implemented in an Indiana community did not hurt business at the off-track betting facility in that community. The findings, the researchers said, suggest there is "no economic reason for policymakers to exclude OTB facilities from smoke-free legislation."

MTN-007 phase trial evaluates vaginal microbicide to prevent rectal transmission of HIV

Tenofovir gel, a vaginal microbicide that has shown promise for preventing HIV through vaginal sex, is being tested in a new trial looking at its safety and acceptability when used rectally. The results of the study, being led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), will help determine if the gel should be evaluated further for its potential to prevent HIV among both men and women who engage in receptive anal intercourse.

Medtronic's Q1 financial results announced

Medtronic, Inc. (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2010, which ended July 31, 2009.

Group says it has Kansas clinic abortion records; Iowa preps for abortion battle in budget

An anti-abortion group says it has patient records of dozens of women and girls who sought treatment at a Kansas abortion clinic last month. In the meantime, Iowa lawmakers prepare to tackle the state's health spending, including whether victims of rape or incest may get abortions through its Medicaid program.

Aeja Weiss, MD - Dermatology in Apo, AP